251 related articles for article (PubMed ID: 18942057)
1. Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis.
Kerr SF; Norton S; Glynne-Jones R
Br J Surg; 2008 Dec; 95(12):1534-40. PubMed ID: 18942057
[TBL] [Abstract][Full Text] [Related]
2. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
[TBL] [Abstract][Full Text] [Related]
3. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
4. Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy.
Valenti V; Hernandez-Lizoain JL; Baixauli J; Pastor C; Aristu J; Diaz-Gonzalez J; Beunza JJ; Alvarez-Cienfuegos JA
Ann Surg Oncol; 2007 May; 14(5):1744-51. PubMed ID: 17334851
[TBL] [Abstract][Full Text] [Related]
5. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
[TBL] [Abstract][Full Text] [Related]
6. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
Sloothaak DA; Geijsen DE; van Leersum NJ; Punt CJ; Buskens CJ; Bemelman WA; Tanis PJ;
Br J Surg; 2013 Jun; 100(7):933-9. PubMed ID: 23536485
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation increases the risk of pelvic sepsis after radical excision of rectal cancer.
Buie WD; MacLean AR; Attard JA; Brasher PM; Chan AK
Dis Colon Rectum; 2005 Oct; 48(10):1868-74. PubMed ID: 16175323
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer.
Swellengrebel HA; Marijnen CA; Verwaal VJ; Vincent A; Heuff G; Gerhards MF; van Geloven AA; van Tets WF; Verheij M; Cats A
Br J Surg; 2011 Mar; 98(3):418-26. PubMed ID: 21254020
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer.
Fietkau R; Barten M; Klautke G; Klar E; Ludwig K; Thomas H; Brinckmann W; Friedrich A; Prall F; Hartung G; Küchenmeister U; Kundt G
Dis Colon Rectum; 2006 Sep; 49(9):1284-92. PubMed ID: 16758130
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgery.
Ulrich A; Weitz J; Slodczyk M; Koch M; Jaeger D; Münter M; Büchler MW
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):129-36. PubMed ID: 19304407
[TBL] [Abstract][Full Text] [Related]
12. Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.
Chang GJ; Rodriguez-Bigas MA; Eng C; Skibber JM
Cancer; 2009 Dec; 115(23):5432-40. PubMed ID: 19673001
[TBL] [Abstract][Full Text] [Related]
13. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant therapy and anastomotic leak after tumor-specific mesorectal excision for rectal cancer.
Martel G; Al-Suhaibani Y; Moloo H; Haggar F; Friedlich M; Mamazza J; Poulin EC; Stern H; Boushey RP
Dis Colon Rectum; 2008 Aug; 51(8):1195-201. PubMed ID: 18523823
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting anastomotic complications following anterior resection in rectal cancer.
Lyall A; Mc Adam TK; Townend J; Loudon MA
Colorectal Dis; 2007 Nov; 9(9):801-7. PubMed ID: 17931170
[TBL] [Abstract][Full Text] [Related]
16. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
Katz MS; Minsky BD; Saltz LB; Riedel E; Chessin DB; Guillem JG
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1363-70. PubMed ID: 16029794
[TBL] [Abstract][Full Text] [Related]
17. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer.
Wibe A; Rendedal PR; Svensson E; Norstein J; Eide TJ; Myrvold HE; Søreide O
Br J Surg; 2002 Mar; 89(3):327-34. PubMed ID: 11872058
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the postoperative neutrophil leucocytosis following neoadjuvant chemoradiotherapy for rectal cancer and implications for surgical morbidity.
Kerr SF; Klonizakis M; Glynne-Jones R
Colorectal Dis; 2010 Jun; 12(6):549-54. PubMed ID: 19486105
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C; Valentini V; Cionini L; De Paoli A; Rodel C; Glynne-Jones R; Coco C; Romano M; Mantello G; Palazzi S; Mattia FO; Friso ML; Genovesi D; Vidali C; Gambacorta MA; Buffoli A; Lupattelli M; Favretto MS; La Torre G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):99-107. PubMed ID: 18407433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
